Recall D-0151-2026

US Class II Ongoing · initiated 2025-10-13

Recalling firm

Teva Pharmaceuticals USA, Inc, NJ

Product

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.

Reason for recall

Subpotent drug; Clavulanate Potassium component

← All recalls